1210 related articles for article (PubMed ID: 23816244)
21. [Surgical treatment of differentiated carcinoma of the thyroid. Follow-up of 99 cases].
Pozzetto B; Roseano M; Dellach C; Leggeri A
Chir Ital; 2000; 52(1):49-56. PubMed ID: 10832526
[TBL] [Abstract][Full Text] [Related]
22. Level IIb lymph node metastasis in neck dissection for papillary thyroid carcinoma.
Lee BJ; Wang SG; Lee JC; Son SM; Kim IJ; Kim YK
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1028-30. PubMed ID: 17938327
[TBL] [Abstract][Full Text] [Related]
23. Lymph nodes metastases in differentiated thyroid cancer--prognostic value and surgical results with 430 patients for 30 years period (1980-2010).
Petkov R; Katev N; Todorov G; Mladenovski V; Yaramov N; Sokolov M
Khirurgiia (Sofiia); 2011; (1):5-11. PubMed ID: 23847796
[TBL] [Abstract][Full Text] [Related]
24. Importance of lymph node metastases in follicular thyroid cancer.
Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
[TBL] [Abstract][Full Text] [Related]
25. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
[TBL] [Abstract][Full Text] [Related]
27. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma.
Vergez S; Sarini J; Percodani J; Serrano E; Caron P
Eur J Surg Oncol; 2010 Aug; 36(8):777-82. PubMed ID: 20584589
[TBL] [Abstract][Full Text] [Related]
28. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172
[TBL] [Abstract][Full Text] [Related]
29. Skip metastases in thyroid cancer leaping the central lymph node compartment.
Machens A; Holzhausen HJ; Dralle H
Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
[TBL] [Abstract][Full Text] [Related]
30. Peroperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland.
Hamming JF; van de Velde CJ; Goslings BM; Fleuren GJ; Hermans J; Delemarre JF; van Slooten EA
Surg Gynecol Obstet; 1989 Aug; 169(2):107-14. PubMed ID: 2667172
[TBL] [Abstract][Full Text] [Related]
31. [Lymphadenectomy in thyroid gland carcinoma--staging and therapy].
Pomorski L; Rybinski K
Zentralbl Chir; 1996; 121(6):455-8. PubMed ID: 8767330
[TBL] [Abstract][Full Text] [Related]
32. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatment of differentiated thyroid carcinoma in children.
Bingöl-Koloğlu M; Tanyel FC; Senocak ME; Büyükpamukçu N; Hiçsönmez A
Eur J Pediatr Surg; 2000 Dec; 10(6):347-52. PubMed ID: 11215773
[TBL] [Abstract][Full Text] [Related]
34. [Pro and contra lymphadenectomy in papillary and follicular thyroid gland carcinoma].
Seiler CA; Schäfer M; Büchler MW
Zentralbl Chir; 2000; 125(10):835-40; discussion 840-1. PubMed ID: 11098579
[TBL] [Abstract][Full Text] [Related]
35. [Clinical evaluation of management of superior mediastinal metastasis from thyroid carcinoma with systemic superior mediastinal dissection via sternotomy approach: 12 cases report].
Zhang Q; Guo ZM; Fu JH; Zeng ZY; Chen FJ; Wei MW; Wu GH; Yang AK
Ai Zheng; 2004 Jul; 23(7):842-4. PubMed ID: 15248925
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.
Pilaete K; Delaere P; Decallonne B; Bex M; Hauben E; Nuyts S; Clement P; Hermans R; Vander Poorten V
B-ENT; 2012; 8(2):113-21. PubMed ID: 22896930
[TBL] [Abstract][Full Text] [Related]
37. [Surgical therapy of differentiated thyroid gland carcinoma].
Walgenbach S; Sternheim E; Bittinger F; Junginger T
Zentralbl Chir; 1997; 122(4):252-8. PubMed ID: 9221635
[TBL] [Abstract][Full Text] [Related]
38. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
39. [Significance of level VI neck dissection in surgical operation for thyroid cancer].
Song M; Chen WK; Chen FJ; Yang AK; Wei MW
Ai Zheng; 2006 Nov; 25(11):1411-3. PubMed ID: 17094911
[TBL] [Abstract][Full Text] [Related]
40. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
